Capital Impact Advisors, LLC - Q4 2020 holdings

$407 Million is the total value of Capital Impact Advisors, LLC's 102 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .

 Value Shares↓ Weighting
TWST BuyTWIST BIOSCIENCE CORP$13,705,000
+351.0%
97,000
+142.5%
3.36%
+273.5%
NTLA BuyINTELLIA THERAPEUTICS INC$11,968,000
+447.2%
220,000
+100.0%
2.94%
+353.5%
NVTA BuyINVITAE CORP$11,498,000
+32.6%
275,000
+37.5%
2.82%
+9.9%
EXAS BuyEXACT SCIENCES CORP$9,235,000
+40.0%
69,702
+7.7%
2.27%
+16.0%
ROKU BuyROKU INC$9,167,000
+124.7%
27,609
+27.8%
2.25%
+86.2%
EDIT BuyEDITAS MEDICINE INC$9,114,000
+1198.3%
130,000
+420.0%
2.24%
+976.0%
VCYT NewVERACYTE INC$8,809,000180,000
+100.0%
2.16%
PSNL BuyPERSONALIS INC$7,885,000
+352.6%
215,380
+168.0%
1.94%
+275.2%
PACB NewPACIFIC BIOSCIENCES CALIF IN$7,782,000300,000
+100.0%
1.91%
SQ BuySQUARE INCcl a$7,726,000
+121.1%
35,500
+65.1%
1.90%
+83.1%
TDOC BuyTELADOC HEALTH INC$6,838,000
+149.5%
34,196
+173.6%
1.68%
+106.8%
TWLO BuyTWILIO INCcl a$6,770,000
+82.7%
20,000
+33.3%
1.66%
+51.4%
ARCT BuyARCTURUS THERAPEUTICS HLDGS$6,724,000
+42.5%
155,000
+40.9%
1.65%
+18.0%
ZS BuyZSCALER INC$6,291,000
+105.6%
31,500
+44.8%
1.54%
+70.3%
MASI BuyMASIMO CORP$6,132,000
+63.9%
22,850
+44.2%
1.51%
+35.8%
TRUP BuyTRUPANION INC$5,866,000
+90.6%
49,000
+25.6%
1.44%
+57.9%
SGEN NewSEAGEN INC$4,848,00027,679
+100.0%
1.19%
NVDA BuyNVIDIA CORPORATION$4,586,000
+24.9%
8,783
+29.5%
1.13%
+3.5%
FSLY NewFASTLY INCcl a$4,369,00050,000
+100.0%
1.07%
DDOG BuyDATADOG INC$4,331,000
+76.6%
44,000
+83.3%
1.06%
+46.2%
GRWG NewGROWGENERATION CORP$4,022,000100,000
+100.0%
0.99%
OKTA BuyOKTA INCcl a$3,814,000
+137.8%
15,000
+100.0%
0.94%
+97.1%
ZYXI BuyZYNEX INC$3,709,000
+8.6%
275,534
+40.8%
0.91%
-10.0%
VEEV BuyVEEVA SYS INC$3,208,000
+37.7%
11,785
+42.2%
0.79%
+14.0%
PSTG NewPURE STORAGE INCcl a$3,165,000140,000
+100.0%
0.78%
CARG BuyCARGURUS INC$3,061,000
+204.6%
96,464
+107.6%
0.75%
+152.3%
FATE NewFATE THERAPEUTICS INC$2,910,00032,000
+100.0%
0.72%
MDGL NewMADRIGAL PHARMACEUTICALS INC$2,707,00024,351
+100.0%
0.66%
PHR NewPHREESIA INC$2,387,00044,000
+100.0%
0.59%
BEAM NewBEAM THERAPEUTICS INC$2,041,00025,000
+100.0%
0.50%
HUYA NewHUYA INC$1,993,000100,000
+100.0%
0.49%
SDGR NewSCHRODINGER INC$1,980,00025,000
+100.0%
0.49%
CLLS NewCELLECTIS S Aspon ads$1,902,00070,300
+100.0%
0.47%
CSTL NewCASTLE BIOSCIENCES INC$1,679,00025,000
+100.0%
0.41%
AQB NewAQUABOUNTY TECHNOLOGIES INC$1,668,000190,400
+100.0%
0.41%
DOYU NewDOUYU INTL HLDGS LTDsponsored ads$1,659,000150,000
+100.0%
0.41%
LI NewLI AUTO INCsponsored ads$1,153,00040,000
+100.0%
0.28%
ACCD NewACCOLADE INC$1,109,00025,500
+100.0%
0.27%
XPEV NewXPENG INCads$857,00020,000
+100.0%
0.21%
BLI NewBERKELEY LTS INC$814,0009,100
+100.0%
0.20%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITED THERAPEUTICS CORP DEL38Q2 20233.1%
AMERESCO INC38Q3 20231.7%
REGENERON PHARMACEUTICALS37Q4 20222.7%
HEALTHSTREAM INC37Q2 20230.9%
INSPERITY INC36Q2 20231.6%
META PLATFORMS INC35Q4 20223.8%
STEEL DYNAMICS INC34Q4 20223.1%
SHUTTERSTOCK INC34Q3 20231.2%
INTERCONTINENTAL EXCHANGE IN33Q4 20221.8%
CLEAN HARBORS INC33Q3 20232.4%

View Capital Impact Advisors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-15
13F-HR2023-08-14
13F-HR2023-05-23
13F-HR2023-02-15
13F-HR2022-11-22
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Capital Impact Advisors, LLC's complete filings history.

Compare quarters

Export Capital Impact Advisors, LLC's holdings